Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

1.4K
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
1.4K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

862
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
862
Drug Therapy01:28

Drug Therapy

353
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
353
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

982
The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
982
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between state cannabis laws and opioid outcomes: A systematic review.

Drug and alcohol dependence·2026
Same author

Identifying demographic predictors of increased non-fatal opioid overdose risk among New York State Medicaid enrollees following the COVID-19 pandemic: an analysis of heterogeneous treatment effects.

Epidemiology (Cambridge, Mass.)·2026
Same author

Geospatial ecological momentary assessment (GEMA) for opioid use disorder: Protocol for a just-in-time adaptive intervention.

Journal of substance use and addiction treatment·2026
Same author

The Earned Income Tax Credit and short-term changes in financial strain and drug use.

Health affairs scholar·2026
Same author

Test-retest reliability of mgTHC consumption in the self-administered Cannabis Exposure Index (CEI).

Drug and alcohol dependence·2026
Same author

Reconstructing Psychopathology: A Data-Driven Reorganization of the Symptoms in the Diagnostic and Statistical Manual of Mental Disorders.

Clinical psychological science : a journal of the Association for Psychological Science·2025

Related Experiment Video

Updated: Mar 7, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K

Mental disorder comorbidity and treatment utilization.

Craig Rodriguez-Seijas1, Nicholas R Eaton1, Malki Stohl2

  • 1Department of Psychology, Stony Brook University, Stony Brook, NY, USA.

Comprehensive Psychiatry
|February 21, 2017
PubMed
Summary

Understanding psychological and substance use disorder comorbidity is key to increasing treatment utilization. Both internalizing and externalizing factors are linked to seeking help, with specific patterns influencing treatment choices.

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.5K

Related Experiment Videos

Last Updated: Mar 7, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
A New Method for Inducing a Depression-Like Behavior in Rats
07:57

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

22.5K

Area of Science:

  • Psychiatry and Mental Health
  • Epidemiology
  • Health Services Research

Background:

  • Effective psychological and substance use disorder treatments are underutilized.
  • Treatment utilization varies by diagnosis, leading to fragmented research.
  • Multivariate comorbidity is common but often overlooked in treatment studies.

Purpose of the Study:

  • To investigate the association between transdiagnostic comorbidity factors and treatment utilization.
  • To examine how internalizing and externalizing factors relate to seeking treatment for mood, anxiety, and substance use disorders.

Main Methods:

  • Utilized a nationally representative sample of US adults (N=34,653).
  • Applied the internalizing-externalizing latent comorbidity model.
  • Examined associations with lifetime utilization of mood, anxiety, and substance use disorder treatments.

Main Results:

  • Both internalizing and externalizing factors positively correlated with all treatment types.
  • Within-domain associations (e.g., internalizing with mood/anxiety treatment) were stronger than between-domain.
  • Observed significant antagonistic interactions between internalizing and externalizing factors.

Conclusions:

  • A nuanced approach to comorbidity modeling is crucial for predicting treatment utilization.
  • Findings highlight the complex interplay of internalizing and externalizing symptoms in treatment-seeking behavior.
  • Results have implications for clinical practice and public health strategies to improve treatment access.